AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Entropy Neurodynamics Ltd

0.038

0.000

Volume:1.88M

Turnover:71.35K

Market Cap:61.98M

PE:-12.24

High:0.038

Open:0.038

Low:0.038

Close:0.038

52wk High:0.043

52wk Low:0.025

Shares:1.63B

Float Shares:878.05M

Volume Ratio:1.97

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.003

EPS(LYR):-0.003

ROE:-73.07%

ROA:-40.38%

PB:8.42

PE(LYR):-12.26

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Entropy Neurodynamics Says First Patient Dosed in Second Group of Phase 2 Binge Eating Disorder Trial

MT Newswires Live

Entropy Neurodynamics Says All Patients Show Improvement in Phase 2 Binge Eating Disorder Trial; Shares Up 3%

MT Newswires Live

Entropy Neurodynamics Ltd - FY Loss Attributable A$4.9 Mln

THOMSON REUTERS

Entropy Neurodynamics Ltd - no Dividends Paid, Recommended or Declared During the Current Financial Period

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ENP.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","market":"AU","secType":"STK","nameCN":"Entropy Neurodynamics Ltd","latestPrice":0.038,"timestamp":1791349920000,"preClose":0.038,"halted":0,"volume":1877633,"delay":0,"changeRate":0,"nameEN":"Entropy Neurodynamics Ltd","floatShares":878046607,"shares":1631064683,"eps":-0.003104,"marketStatus":"Not Yet Opened","change":0,"latestTime":"10-07 16:12:00 AEDT","open":0.038,"high":0.038,"low":0.038,"amount":71350,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003104,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791414000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.038,"openAndCloseTimeList":[[1791327600000,1791349200000]],"volumeRatio":1.9656661444678227,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ENP.AU","preClose":0.038,"auctionPrice":0.038,"auctionVolume":19652,"auctionTime":1791410076061,"referenceTime":1791369003092,"auction":1,"marketStatus":"盘前竞价","timestamp":1791410076061}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","floatShares":878046607,"roa":"-40.38%","roe":"-73.07%","lyrEps":-0.0031,"volumeRatio":1.9656661444678227,"shares":1631064683,"dividePrice":0,"high":0.038,"amplitude":0,"preClose":0.038,"low":0.038,"week52Low":0.025,"pbRate":"8.42","psRate":"32.51","week52High":0.043,"institutionHeld":0,"latestPrice":0.038,"eps":-0.003104,"divideRate":0,"volume":1877633,"delay":0,"ttmEps":-0.003104,"open":0.038,"prevYearClose":0.033,"prevWeekClose":0.039,"prevMonthClose":0.039,"prevQuarterClose":0.039,"fiveDayClose":0.039,"twentyDayClose":0.042,"sixtyDayClose":0.035},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENP.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673829067","title":"Entropy Neurodynamics Says First Patient Dosed in Second Group of Phase 2 Binge Eating Disorder Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673829067","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673829067?lang=en_us&edition=fundamental","pubTime":"2026-10-07 11:39","pubTimestamp":1791344382,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics  said the first patient in the second group of its phase two clinical study evaluating TRP-8803, or IV-infused psilocin, for the potential treatment of binge eating disorder was dosed over a 60-minute period and was safely discharged following all required post-treatment clinical assessments, according to a Wednesday Australian bourse filing.The second group is testing a 60-minute infusion time versus a 140-minute regimen used in the first group, the company said. The patient reported maximum psychedelic intensity during shortened treatment session.The company said reducing treatment duration is an important component of its development strategy. It will observe the consistency of the psychedelic experience, safety, tolerability, and whether improvements in binge eating disorder symptoms and their durability remain evident following the shorter treatment regimen, it added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663244","title":"Entropy Neurodynamics Says All Patients Show Improvement in Phase 2 Binge Eating Disorder Trial; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663244","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663244?lang=en_us&edition=fundamental","pubTime":"2026-09-14 12:05","pubTimestamp":1789358736,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics  said all six treatment-resistant binge eating disorder patients in group 1 of its phase 2 trial of TRP-8803, an intravenously infused psilocin drug candidate, showed a \"clinically meaningful improvement\" in symptoms for the full 12-week follow-up period, according to a Monday Australian bourse filing.The company said 50% of patients experienced no binge-eating episodes during the entire 84-day follow-up period after completing two TRP-8803 infusions, with weekly binge-eating episodes 73% below pretreatment baseline at 12 weeks, substantially maintaining the 74% reduction observed at four weeks.For group 2, the company will evaluate a shorter TRP-8803 infusion period, with top-line results expected in the fourth quarter of the year, the filing added.The company's shares rose almost 3% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662710031","title":"Entropy Neurodynamics Ltd - FY Loss Attributable A$4.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662710031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662710031?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:46","pubTimestamp":1787874390,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031741","title":"Entropy Neurodynamics Ltd - no Dividends Paid, Recommended or Declared During the Current Financial Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031741","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031741?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:46","pubTimestamp":1787874390,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1KB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ENP.AU\",params:#limit:6,delay:true,,,undefined,":[]}}